Addendum to the Guideline on clinical development of vaccines to address clinical trials in immunocompromised individuals
Herbal medicinal product: Pilosellae herba cum radice, Hieracium pilosella L., F: Assessment finalised
Agenda - PDCO agenda of the 25-28 February 2025 meeting
EMEA-003063-PIP02-22
EMEA-000786-PIP01-09-M02
Medicinal products for human use: monthly figures - January 2025
CTIS newsflash - 25 February 2025
Human medicines European public assessment report (EPAR): Brimica Genuair, aclidinium,formoterol fumarate dihydrate, Date of authorisation: 19/11/2014, Revision: 16, Status: Authorised
Human medicines European public assessment report (EPAR): Bretaris Genuair, aclidinium bromide, Date of authorisation: 20/07/2012, Revision: 20, Status: Authorised
PSUSA/00000434/202407